Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Interest Expenses: 2016-2024

Historic Interest Expenses for Organogenesis Holdings (ORGO) over the last 9 years, with Dec 2024 value amounting to $1.5 million.

  • Organogenesis Holdings' Interest Expenses fell 188.11% to -$415,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.1 million, marking a year-over-year decrease of 199.95%. This contributed to the annual value of $1.5 million for FY2024, which is 29.50% down from last year.
  • Per Organogenesis Holdings' latest filing, its Interest Expenses stood at $1.5 million for FY2024, which was down 29.50% from $2.2 million recorded in FY2023.
  • In the past 5 years, Organogenesis Holdings' Interest Expenses registered a high of $11.3 million during FY2020, and its lowest value of $1.5 million during FY2024.
  • In the last 3 years, Organogenesis Holdings' Interest Expenses had a median value of $2.0 million in 2022 and averaged $1.9 million.
  • Its Interest Expenses has fluctuated over the past 5 years, first grew by 25.38% in 2020, then slumped by 72.24% in 2022.
  • Organogenesis Holdings' Interest Expenses (Yearly) stood at $11.3 million in 2020, then tumbled by 35.85% to $7.2 million in 2021, then plummeted by 72.24% to $2.0 million in 2022, then increased by 9.01% to $2.2 million in 2023, then decreased by 29.50% to $1.5 million in 2024.